We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Restore Biodiagnostics Receives Grant To Develop Stress Hormone Test
News

Restore Biodiagnostics Receives Grant To Develop Stress Hormone Test

Restore Biodiagnostics Receives Grant To Develop Stress Hormone Test
News

Restore Biodiagnostics Receives Grant To Develop Stress Hormone Test

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Restore Biodiagnostics Receives Grant To Develop Stress Hormone Test"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Underscoring their commitment to innovative research in the field of diagnostics and personal hormone health, Restore Biodiagnostics, a Restore Health company specializing in hormone testing and other advanced diagnostics, has received a NIH grant to develop a rapid point of care test to determine an individual’s stress level using a single saliva specimen in 15 minutes or less. The test will semi-quantitavely measure the stress hormone Cortisol.

Funding for the $325,000 project is provided by the National Institutes of Health’s National Center for Complementary and Alternative Medicine. The technology under development is based on an immunochromatographic test platform delivering real time immediate results in laboratory or field settings where standard laboratory equipment might not be available.

Phase one of the project will validate the technology against standardized enzyme linked immunosorbent assays (ELISA) for the measurement of stress levels in Cortisol. Phase two of the project will demonstrate the technological effectiveness in laboratory settings under both stressful and non stressful situations. This underpinning will also aid in the development and refinement of protocols with stress research in human clinical trials.

Advertisement